Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-06

Clinical Trial Update: Bleomycin Infusion (MMP®) to Repigment Achromic Scars [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating bleomycin infusion to repigment achromic scars.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bleomycin (bleomycin)

Snippet

Sponsor: Clinica Dermatologica Arbache ltda | Conditions: SCAR | Phase 4 | Status: UNKNOWN